| Chemical Properties | Back Directory | [Boiling point ]
1003.9±75.0 °C(predicted) | [density ]
1.345±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
8.58±0.10(predicted) |
| Hazard Information | Back Directory | [Uses]
NC-III-49-1 is a potent bivalent bromodomain and extraterminal domain (BET) inhibitor. NC-III-49-1 shows binding potential for BRD4-1, BRD4-2, BRD4-T, BRDT-1, BRDT-2, BRDT-T with Kd values of 0.095, 0.32, 0.29, 0.089, 5.5, 0.058 nM, respectively. NC-III-49-1 shows antiproliferative activity. NC-III-49-1 decreases the expression of c-Myc[1]. | [in vivo]
NC-III-49-1 shows metabolic stability in human and mouse liver microsomes with an T1/2 values of <2.3, <2.3 min, respectively[1]. | [IC 50]
BRD4-1: 0.095 nM (Kd); BRD4-2: 0.032 nM (Kd); BRD4-T: 0.29 nM (Kd); BRDT-1: 0.089 nM (Kd); BRDT-2: 5.5 nM (Kd); BRDT-T: 0.058 nM (Kd) | [References]
[1] Guan X, et al. Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. J Med Chem. 2022 Jul 22. DOI:10.1021/acs.jmedchem.2c00453 |
|
|